Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could have a ...

Left-hander Chris Sale and the Atlanta Braves have agreed to a contract adding $27 million for the 2027 season.